Amended Statement of Beneficial Ownership (sc 13d/a)

Date : 07/11/2018 @ 5:31PM
Source : Edgar (US Regulatory)
Stock : Vycor Medical, Inc. (QB) (VYCO)
Quote : 0.29  0.0 (0.00%) @ 7:52AM
Vycor Medical, Inc. (QB) share price Chart

Amended Statement of Beneficial Ownership (sc 13d/a)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13D/A

(Rule 13d-101)

Twenty-Seventh Amendment

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(a)

 

VYCOR MEDICAL, INC.

(Name of Issuer)

 

COMMON STOCK, PAR VALUE $0.0001

(Title of Class of Securities)

 

92921M203

(CUSIP Number)

 

Fountainhead Capital Management Limited

17 Bond Street

St. Helier, Jersey, Channel Islands JE2 3NP

+44 (0)1534 630112

 

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

June 30 , 2018

(Date of Event which Requires Filing Statement on Schedule 13D)

  

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [  ].

 

 

 

 

 

 

CUSIP No. 92921M203 13D  

 

1.

NAMES OF REPORTING PERSONS

 

Fountainhead Capital Management Limited

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [  ]

(b) [  ]

3.

SEC USE ONLY

 

 

4.

SOURCE OF FUNDS

 

OO (See Item 3 below)

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

[  ]

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Jersey, Channel Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7. SOLE VOTING POWER 12,041,165
   
8. SHARED VOTING POWER 0
   
9. SOLE DISPOSITIVE POWER 12,041,165
   
10. SHARED DISPOSITIVE POWER 0
   

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

12,041,165

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

[  ]

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

52.63 %

14.

TYPE OF REPORTING PERSON

 

CO

 

 

 

 

EXPLANATORY NOTE

 

The purpose of this Schedule 13D filing is to update the ownership of Vycor Medical, Inc. (“the Company”) Common Stock, par value $0.0001 (“Vycor Common Shares”). On June 30, 2018, the Company issued to Fountainhead an aggregate of 340,909 shares of Company Common Stock pursuant to its Fountainhead Consultancy Agreement. As a result of such issuance, Fountainhead’s previously-reporting holdings of Vycor Common Stock (including shares which it has the option to acquire within sixty (60) days of such date) were adjusted to a total of 12,041,165 shares, comprising ownership of 11,381,165 Vycor Common Shares and Options to purchase 660,000 Vycor Common Shares at $0.27 per share for a period of three (3) years from June 30, 2018. In addition, on June 30, 2018, Vycor issued to Fountainhead options to purchase an additional 660,000 shares of Vycor common stock at $0.46 per share for a period of three years from the date of vesting. Vesting shall occur upon the achievement of certain milestones prior to June 30, 2019. It is not yet known if the required milestones will be achieved within 60 days of the date of this report and, as a result thereof, these shares have not been included in the shares listed above.

 

This Schedule 13D is being filed by Fountainhead Capital Management Limited to disclose its ownership of approximately 52.63% of the Company’s outstanding Common Stock.

 

Item 1. Security and Issuer.

 

The name of the issuer is Vycor Medical, Inc., a Delaware corporation which has its principal offices at 951 Broken Sound Boulevard. Suite 320, Boca Raton, FL 33487. This statement relates to the Company’s common stock, $0.0001 par value per share.

 

Item 2. Identity and Background.

 

(a). This Schedule 13D is being filed by Fountainhead Capital Management Limited, a Jersey, C.I. corporation, which has its principal offices at 17 Bond Street, St. Helier, Jersey, Channel Islands JE2 3NP (the “Reporting Person”).

 

During the last five years, the Reporting Person has not been (A) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (B) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.

 

Item 3. Source and Amount of Funds or Other Consideration.

 

The reporting person received 340,909 shares of Company Common Stock pursuant to its Fountainhead Consultancy Agreement.

 

Item 4. Purpose of Transaction.

 

The reporting person received 340,909 shares of Company Common Stock pursuant to its Fountainhead Consultancy Agreement.

 

Except as set forth in this Schedule 13D, the Reporting Person has made no proposals, and has entered into no agreements, which would be related to or would result in any of the events or matters described in part (a) through (j) of Item 4 of Schedule 13D.

 

 

 

 

Item 5. Interest in Securities of the Issuer.

 

(a) The Reporting Person is the beneficial owner of 12,041,165 shares of the Company’s common stock, representing approximately 52.63% of the outstanding shares of the Company’s common stock. Said amount includes all shares issuable to the Reporting Person on account of all Warrants or Options held by the Reporting Person convertible or exercisable within sixty (60) days of the date of this report. Other than as described therein, the Reporting Person does not own any other securities of the Company. The holder believes the number of shares of the Company’s outstanding common stock including Fountainhead’s Warrants exercisable within sixty (60) days of the date of this report to be 22,877,049 as of June 30, 2018.
   
(b) The Reporting Person has the sole power to vote and dispose of the 12,041,165 shares, less the number of shares which are currently subject to issuance only upon the exercise of Warrants or Options.
   
(c) Except for the transactions described in the Explanatory Note above, the Reporting Person did not effect any transactions in the issuer’s securities within the past 60 days.
   
(d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Reporting Person’s securities.
   
(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

 

Except as described in the Explanatory Note, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Person and any other person with respect to any securities of the issuer, including, but not limited to transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

 

Item 7. Material to be Filed as Exhibits.

 

None

 

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: July 11 , 2018    
     
  By:

/s/ Claire Louise Farrow

  Name:

Claire Louise Farrow,

    Director

 

  By:

/s/ Claire Louise Machin

  Name:

Claire Louise Machin,

    Director

 

 

 

 

Vycor Medical, Inc. (QB) (USOTC:VYCO)
Historical Stock Chart

1 Year : From Jul 2017 to Jul 2018

Click Here for more Vycor Medical, Inc. (QB) Charts.

Vycor Medical, Inc. (QB) (USOTC:VYCO)
Intraday Stock Chart

Today : Sunday 22 July 2018

Click Here for more Vycor Medical, Inc. (QB) Charts.

Latest VYCO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20180722 10:45:26